SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Indrayani Biotech’s arm to invest in Kniss Laboratories

14 Apr 2023 Evaluate

Indrayani Biotech’s wholly owned subsidiary -- M/s IBL Healthcare is planning to invest in M/s Kniss Laboratories by subscribing to the company's proposed issuance of Compulsory Convertible Debentures (CCDs). Kniss Laboratories is a pharma manufacturing unit certified by ISO 9001-2008 for quality compliance and awarded good manufacturing practice license by state drug authority of India.

Indrayani Biotech is a company belonging to food sector. They are a part-finance its project to produce cut flowers, strawberries, tissue culture plantlets and hybrid vegetable seeds. The company also markets and distributes hybrid vegetable seeds manufactured by Hoechst India. It plans to produce these seeds for Hoechst in due course of time.

Indrayani Biotech Share Price

11.31 0.02 (0.18%)
05-Jun-2026 09:20 View Price Chart
Peers
Company Name CMP
Grasim Industries 3114.60
DCM Shriram 1022.35
3M India 32390.75
Hindustan Foods 540.45
Balmer Lawrie & Co 183.65
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×